SRF (SRF) investor relations material

Executive summary

• Achieved record quarterly performance in Q1 FY 2027, with consolidated revenue up 31.8% and PAT up 75.5%, driven by diversified business portfolio and operational excellence.

• All business segments contributed to growth, with margin expansion and operational improvements.

• Strategic investments advanced in capacity expansion, product portfolio broadening, and innovation, positioning for sustainable long-term growth.

• Recognized externally for supply chain and customer relationship excellence.

• Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Financial highlights

• Consolidated revenue from operations reached INR 5,033.3 crore, up from INR 3,818.6 crore year-over-year.

• Operational EBIT rose 61% year-over-year to INR 1,116 crore, with an EBIT margin of 22%.

• EBITDA grew 61.4% to INR 1,372.6 crore, with EBITDA margin improving to 27.3%.

• Profit after tax increased 76% year-over-year to INR 759 crore, with PAT margin rising to 15.1%.

• Interim dividend of INR 5 per equity share approved, totaling INR 148.21 crore.

Outlook and guidance

• Expect sequential normalization in Q2 due to seasonality, but year-over-year growth to continue.

• Chemicals business guidance maintained at 15%-20% growth for FY 2027, with potential to reach higher end due to strong Q1.

• Specialty Chemicals expects further product launches and volume growth in pharma; early signs of agrochemical demand recovery.

• Fluoropolymer and specialty chemicals to drive future growth as new capacities and customer approvals ramp up.

• Performance Films margins expected to stabilize at a higher baseline post Q1, with normalization in Q2.